Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06427330
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-05-10
Brief Title:
Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia
Sponsor:
Organization:
Institute of Hematology Blood Diseases Hospital China